Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
KCNS1 encodes the **Potassium voltage-gated channel modifier subfamily S member 1**, a regulatory (electrically silent) subunit of the voltage-gated potassium channel family. It does not form functional channels by itself but modulates the activity of functional alpha subunits of other potassium channels, particularly KCNB1 and KCNB2, by altering their kinetics, voltage-dependence, and expression levels. KCNS1 is implicated in the regulation of neuronal excitability and modulation of action potential firing, and variants in KCNS1 have been associated with inherited episodes of pain. Dysfunction or altered expression of KCNS1-containing channel complexes may thus contribute to neuropathic pain conditions[2].
Modulation of KCNB1 and KCNB2 channel activity when forming heteromultimeric channels (influencing current kinetics, expression levels, voltage-dependence)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Potassium voltage-gated channel modifier subfamily S member 1 (KCNS1).